A | Cutoff date | B | A–B p value | C | B–C p value | First A–C publication (year) |
---|---|---|---|---|---|---|
Tumorigenesis | 2001 | AHR | 9 × 10–7 | Inflammation | 6 × 10–138 | 17848686 (2007) |
CD44 | 6 × 10–45 | 5 × 10–93 | 7530464 (1994) | |||
FAS | 3 × 10–23 | 8 × 10–107 | 10358186 (1999) | |||
REL | 5 × 10–10 | 7 × 10–35 | 15197457 (2004) | |||
JUN | 4 × 10–40 | 1 × 10–36 | 10657993 (2000) | |||
FOS | 5 × 10–42 | 7 × 10–38 | 10657993 (2000) | |||
HGF | 5 × 10–34 | 9 × 10–22 | 14596869 (2003) | |||
STAT1 | 2 × 10–7 | 3 × 10–13 | 16734720 (2006) | |||
APC | 3 × 10–263 | 1 × 10–26 | 8672984 (1995) | |||
STAT3 | 4 × 10–7 | 4 × 10–12 | 12219085 (2002) | |||
LOX | 7 × 10–6 | 5 × 10–9 | N/A | |||
DES | 6 × 10–28 | 4 × 10–23 | N/A | |||
PCNA | 1 × 10–59 | 5 × 10–12 | 20975039 (2010) | |||
EGF | 5 × 10–78 | 1 × 10–6 | 7895532 (1995) |